FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
ADHD On The Rise In US: 6 Percent Of Adults Affected, Treatment Disrupted Due To Drug Shortages
A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...
3 No-Brainer Growth Stocks to Buy in October
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
10 Best Supplements for Weight Loss, According to a Dietitian
A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.
How a medtech market opportunity is shaping up for wearable neurotech
When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.